New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
09:02 EDTACTGAcacia reaches settlement with Mallinckrodt over Exalgo
Actavis announced that it has reached a settlement with Mallinckrodt on outstanding patent litigation related to Actavis' generic version of the 32 mg dosage strength of Mallinckrodt's Exalgo tablets. In January of 2012, Actavis and Mallinckrodt previously settled litigation involving the 8 mg, 12 mg and 16 mg dosage strengths of the product. Under terms of the settlement agreement, Mallinckrodt has granted Actavis a royalty-free license to U.S. patents relating to Exalgo to sell Actavis' 32 mg product starting on May 15, 2014. Other details of the settlement were not disclosed.
News For ACTG From The Last 14 Days
Check below for free stories on ACTG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
08:30 EDTACTGAcacia Research has a conference call hosted by JPMorgan
Subscribe for More Information
August 26, 2014
06:03 EDTACTGAcacia subsidiary enters settlement, license agreement with Consolidated Comm.
Subscribe for More Information
August 21, 2014
06:04 EDTACTGAcacia Research enters into settlement, patent license agreement with Autodesk
Subscribe for More Information
August 20, 2014
05:59 EDTACTGAcacia Research enters into agreement with Sharp
Acacia Research Corporation (ACTG) announced that its Cell and Network Selection subsidiary has entered into a patent license agreement with Sharp Corporation (SHCAY).
August 19, 2014
06:03 EDTACTGAcacia Research subsidiaries enter into agreement with RPX
Subscribe for More Information
August 17, 2014
20:39 EDTACTGPatent overhaul efforts seem to have stalled before November election, WSJ says
Legal experts say that it is unlikely that a full Congress will revisit the issue of patent reform before the election in November, says the Wall Street Journal. Large technology companies like Google (GOOG) and Microsoft (MSFT) are pushing Congress to reform patent laws to curb litigation from patent-holding firms, added the Wall Street Journal. Publicly traded companies in the space include Acacia Research (ACTG), Tessera (TSRA), Rambus (RMBS) InterDigital (IDCC) and Vringo (VRNG). Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use